As Chief Operating Officer, Mr. Greenhalgh oversees all operations of TRHC’s Medwise® Healthcare and CareVention Healthcare Divisions, as well as Project & Program Management. His responsibilities include oversight of all operations, care management, inventory, purchasing, and capital planning across the network of TRHC’s CareKinesis pharmacies in New Jersey, Colorado, and California offices.
Mr. Greenhalgh was a founding member of CareKinesis, which grew into TRHC. Mr. Greenhalgh was the chief architect and designer of all pharmacy operations. Mr. Greenhalgh integrated various pharmacy automation technologies and engineered a work flow to drive operational efficiencies and greater profitability. He has been instrumental in procuring and implementing the first deployment in the United States of an advance robotic, multi-dose adherence packaging dispensing system.
Recognized for these achievements, he was the recipient of SmartCEO magazine’s 2015 COO Executive Management Award.
Mr. Greenhalgh brings more than 25 years of professional experience in pharmacy and related healthcare companies. He has established an impressive successful track record as an entrepreneur, including owning and operating nine successful companies from start-up to acquisition in numerous industries. He has exemplary management, leadership, analytical and problem-solving abilities. Prior to CareKinesis, Mr. Greenhalgh was Co-founder and President of Myofacial Associates, a professional wellness center specializing in a natural, alternative medicine approach to patient care with emphasis on well care visits. After 3 years of 100% year-over-year growth from 2003 to 2006, the company was acquired by a Professional Physician Practice.
Earlier, Mr. Greenhalgh was the President and owner of Red Fern Pharmacy, Norris Hills Pharmacy, and Red Fern Medical Inc. Red Fern Pharmacy and Norris Hills Pharmacy became leaders in health education and pharmaceutical care for various disease states and hospice care. Red Fern Medical specialized in diabetes care, medical supplies, and breast prosthesis for breast cancer patients. After ten years of over 200% growth, all three companies were acquired by Rite Aid, a Fortune 500 Company.
Mr. Greenhalgh graduated from Temple University with a bachelor’s degree in Pharmacy.
What is Michael Greenhalgh's net worth?
The estimated net worth of Michael Greenhalgh is at least $1.75 million as of August 5th, 2021. Mr. Greenhalgh owns 166,419 shares of Tabula Rasa HealthCare stock worth more than $1,747,400 as of April 24th. This net worth approximation does not reflect any other investments that Mr. Greenhalgh may own. Additionally, Mr. Greenhalgh receives a salary of $630,900.00 as COO at Tabula Rasa HealthCare. Learn More about Michael Greenhalgh's net worth.
How old is Michael Greenhalgh?
What is Michael Greenhalgh's salary?
As the COO of Tabula Rasa HealthCare, Inc., Mr. Greenhalgh earns $630,900.00 per year. The highest earning executive at Tabula Rasa HealthCare is Mr. Brian W. Adams, CEO, President & Director, who commands a salary of $668,210.00 per year. Learn More on Michael Greenhalgh's salary.
How do I contact Michael Greenhalgh?
Has Michael Greenhalgh been buying or selling shares of Tabula Rasa HealthCare?
Michael Greenhalgh has not been actively trading shares of Tabula Rasa HealthCare during the last quarter. Most recently, on Tuesday, March 1st, Michael Greenhalgh bought 2,000 shares of Tabula Rasa HealthCare stock. The stock was acquired at an average cost of $5.63 per share, with a total value of $11,260.00. Learn More on Michael Greenhalgh's trading history.
Who are Tabula Rasa HealthCare's active insiders?
